iBio has entered into a collaboration with EdgePoint AI, a division of Mateon Therapeutics, to deploy EdgePoint’s proprietary artificial intelligence (AI)/blockchain-driven vision system for pharmaceutical manufacturing, known as TrustPoint Fabric. Initial implementation will occur at iBio’s state-of-the-art production facility for the optimization of raw material documentation and verification activities.   Using blockchain technology, TrustPoint Fabric enables automated data generation and cap...